Jinzhao Song

Jinzhao Song is a Professor at the Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang Cancer Hospital. Prior to this role, he served as a Research Assistant Professor at the University of Pennsylvania, School of Engineering and Applied Science. Dr. Song received his Ph.D. from the Institute of Chemistry, Chinese Academy of Sciences (ICCAS). With over 15 years of experience, he has focused on developing next generation molecular diagnostic systems based on isothermal nucleic acid amplification; microfluidic chip that utilize smartphones for detection, analysis, result recording and sharing; and programmable enzymes such as Argonaute and CRISPR-Cas proteins. Dr. Song has co-authored 51 peerreviewed papers with H-index 23, 15 of which he was the lead author, and was named as co-inventor in 9 granted patents and 10 patent applications. He is a recipient of the NIH K01 Research Scientist Development Award, as well as a PI/co-PI of an R21 NIH grant and two venture incubation programs. His contributions to the field of molecular diagnostics earned him the AACC's "2019 Young Investigator Award for Outstanding Research in Personalized Medicine." Additionally, Dr. Song founded EzDx Technology Inc., an enterprise dedicated to the commercialization and widespread adoption of these cutting-edge diagnostic tools, thereby setting a new standard in healthcare diagnostics and personalized medicine.